InMed Pharmaceuticals Inc (INM)

[Aladdin80]

The bio-identical vs synthetic is a valid argument that some therapeutic providers may care about more than others. The bacteria vs yeast platform is irrelevant to the research entities and/or pharma co's as long as $$ and purity are good. I like that InMed is in an unclogged area when compared to yeast delivery, but can they and will they produce? They've hit hurdles and this is no longer a secret thanks to Eric Hsu's honest update on the Biz update call. I hope they've cleared that hurdle.

Let's not speculate on if Teewinot's cannabinoids are cost effective, highest purity, or anything else for that matter as we all have no clue. All that I can say for a fact is that they have real IP/patents and currently InMed has 0. I can also say that they were first to offer biosynthesized cannabinoids commercially. Quality, cost, etc are of course unknowns. AT least the clock is finally ticking down on who in this rather large and growing field (biosynthesized cannabinoids) is going to succeed.